NZBIO delegates pick Aroa Biosurgery for top honour
(from left): Dr Barnaby May (VP Technology), Dr Jared Scarlett from sponsors Baldwins, Dr Will Barker CEO of NZBIO, James Agnew (CFO) and Simone Von Fircks (VP Operations)
Aroa Biosurgery has been named as New Zealand’s Bioscience Company of the Year at the 2015 NZBIO Conference Awards at Te Papa, Wellington.
Dr Will Barker, CEO of NZBIO, said Aroa is targeting the international biosurgery market with its Reinforced Bioscaffold portfolio for abdominal wall reconstructions, including complex hernia. It has already sold more than one million units of its Endoform Dermal Template™, which is used in diabetic and venous ulcers treatments, in the United States.
“Aroa delivers high quality, simple-to-use products that significantly improve healing outcomes,” Dr Barker said. “It produces a world leading biomaterial building block and has established a new manufacturing facility that has the capacity to meet demand over the next four to five years.”
This year’s winners were judged by their peers at the NZBIO conference using a mobile phone app.